Clearpoint Neuro, functional neurosurgery platform with rapid growth within the biologics & gen therapy segment. Breakout out of a multi-year trend with re-test of previous resistance level on low volume. Expecting this to pop over the the next few months with the continued net growth and EPS.
Dasher, Dancer, Prancer, Vixen, Comet, Cupid, Donner and Blitzen.
Spring and Phase C action, setting up for a bigger rally on the upside.